These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9826461)

  • 1. Combination of transforming growth factor beta antisense and interleukin-2 gene therapy in the murine ovarian teratoma model.
    Dorigo O; Shawler DL; Royston I; Sobol RE; Berek JS; Fakhrai H
    Gynecol Oncol; 1998 Nov; 71(2):204-10. PubMed ID: 9826461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotide specific for transforming growth factor-beta 1 inhibit both in vitro and in vivo growth of MBT-2 murine bladder cancer.
    Tzai TS; Lin CI; Shiau AL; Wu CL
    Anticancer Res; 1998; 18(3A):1585-9. PubMed ID: 9673374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of an antisense transforming growth factor-beta1 transgene reduces tumorigenicity of EMT6 mammary tumor cells.
    Park JA; Wang E; Kurt RA; Schluter SF; Hersh EM; Akporiaye ET
    Cancer Gene Ther; 1997; 4(1):42-50. PubMed ID: 9012450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
    Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
    Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
    Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile.
    Horton HM; Dorigo O; Hernandez P; Anderson D; Berek JS; Parker SE
    J Immunol; 1999 Dec; 163(12):6378-85. PubMed ID: 10586027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with TGF-beta antisense oligonucleotide-modified autologous tumor vaccine enhances the antitumor immunity of MBT-2 tumor-bearing mice through upregulation of MHC class I and Fas expressions.
    Tzai TS; Shiau AL; Liu LL; Wu CL
    Anticancer Res; 2000; 20(3A):1557-62. PubMed ID: 10928070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.
    Larchian WA; Horiguchi Y; Nair SK; Fair WR; Heston WD; Gilboa E
    Clin Cancer Res; 2000 Jul; 6(7):2913-20. PubMed ID: 10914741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8.
    Rahimi F; Hsu K; Endoh Y; Geczy CL
    FEBS J; 2005 Jun; 272(11):2811-27. PubMed ID: 15943814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.
    Suzuki E; Kapoor V; Cheung HK; Ling LE; DeLong PA; Kaiser LR; Albelda SM
    Clin Cancer Res; 2004 Sep; 10(17):5907-18. PubMed ID: 15355924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines.
    Kobie JJ; Wu RS; Kurt RA; Lou S; Adelman MK; Whitesell LJ; Ramanathapuram LV; Arteaga CL; Akporiaye ET
    Cancer Res; 2003 Apr; 63(8):1860-4. PubMed ID: 12702574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of cytokine gene expression during the in vitro CTL induction against a murine nonimmunogenic tumor.
    Murata S; Eguchi Y; Mekata E; Tani T; Kodama M
    Anticancer Res; 2000; 20(1A):363-72. PubMed ID: 10769681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of macrophage transforming growth factor-beta messenger RNA expression by IL-7.
    Dubinett SM; Huang M; Dhanani S; Wang J; Beroiza T
    J Immunol; 1993 Dec; 151(12):6670-80. PubMed ID: 8258684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy.
    Won J; Kim H; Park EJ; Hong Y; Kim SJ; Yun Y
    Cancer Res; 1999 Mar; 59(6):1273-7. PubMed ID: 10096559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in mice.
    Shah AH; Tabayoyong WB; Kundu SD; Kim SJ; Van Parijs L; Liu VC; Kwon E; Greenberg NM; Lee C
    Cancer Res; 2002 Dec; 62(24):7135-8. PubMed ID: 12499244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.